Literature DB >> 15895460

Determination of variants in the 3'-region of the tyrosinase gene requires locus specific amplification.

Moumita Chaki1, Arijit Mukhopadhyay, Kunal Ray.   

Abstract

Mutations in the Tyrosinase gene (TYR, 11q14-q21) cause oculocutaneous albinism type 1 (OCA1). The 3'-region of the TYR shows 98.55% sequence identity with a pseudogene, known as Tyrosinase-Like Gene (TYRL, 11p11.2-cen). A large number of publicly available nucleotide variants of TYR in this region are same as the bases present in the identical locations in the pseudogene. PCR amplification of these regions using primers with sequences common to both loci may result in coamplification of TYR and TYRL, and may lead to misinterpretation of the results. We have resolved this potential problem using locus-specific amplification conditions that could be used to identify unequivocally mutations and SNPs in exon 4 and exon 5 of TYR and proximal flanking sequences.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895460     DOI: 10.1002/humu.20171

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  13 in total

1.  Clinical evaluation and molecular screening of a large consecutive series of albino patients.

Authors:  Lucia Mauri; Emanuela Manfredini; Alessandra Del Longo; Emanuela Veniani; Manuela Scarcello; Roberta Terrana; Adriano Egidio Radaelli; Donata Calò; Giuseppe Mingoia; Antonella Rossetti; Giovanni Marsico; Marco Mazza; Giovanni Pietro Gesu; Maria Cristina Patrosso; Silvana Penco; Elena Piozzi; Paola Primignani
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

2.  Molecular and clinical characterization of albinism in a large cohort of Italian patients.

Authors:  Annagiusi Gargiulo; Francesco Testa; Settimio Rossi; Valentina Di Iorio; Simona Fecarotta; Teresa de Berardinis; Antonello Iovine; Adriano Magli; Sabrina Signorini; Elisa Fazzi; Maria Silvana Galantuomo; Maurizio Fossarello; Sandro Montefusco; Alfredo Ciccodicola; Alberto Neri; Claudio Macaluso; Francesca Simonelli; Enrico Maria Surace
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

3.  Molecular analysis of Korean patients with oculocutaneous albinism.

Authors:  Shin Hae Park; Hyojin Chae; Yonggoo Kim; Myungshin Kim
Journal:  Jpn J Ophthalmol       Date:  2011-11-01       Impact factor: 2.447

4.  Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.

Authors:  Monika B Dolinska; Nicole J Kus; S Katie Farney; Paul T Wingfield; Brian P Brooks; Yuri V Sergeev
Journal:  Pigment Cell Melanoma Res       Date:  2017-01       Impact factor: 4.693

5.  Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population.

Authors:  Thomas J Jaworek; Tasleem Kausar; Shannon M Bell; Nabeela Tariq; Muhammad Imran Maqsood; Asma Sohail; Muhmmmad Ali; Furhan Iqbal; Shafqat Rasool; Saima Riazuddin; Rehan S Shaikh; Zubair M Ahmed
Journal:  Orphanet J Rare Dis       Date:  2012-06-26       Impact factor: 4.123

6.  Spectrum of candidate gene mutations associated with Indian familial oculocutaneous and ocular albinism.

Authors:  Kathirvel Renugadevi; Asim Kumar Sil; Vijayalakshmi Perumalsamy; Periasamy Sundaresan
Journal:  Mol Vis       Date:  2010-08-09       Impact factor: 2.367

7.  Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B).

Authors:  Chelsea S Norman; Luke O'Gorman; Jane Gibson; Reuben J Pengelly; Diana Baralle; J Arjuna Ratnayaka; Helen Griffiths; Matthew Rose-Zerilli; Megan Ranger; David Bunyan; Helena Lee; Rhiannon Page; Tutte Newall; Fatima Shawkat; Christopher Mattocks; Daniel Ward; Sarah Ennis; Jay E Self
Journal:  Sci Rep       Date:  2017-06-30       Impact factor: 4.379

8.  Delineating the genetic heterogeneity of OCA in Hungarian patients.

Authors:  Beáta Fábos; Katalin Farkas; Lola Tóth; Adrienn Sulák; Kornélia Tripolszki; Mariann Tihanyi; Réka Németh; Krisztina Vas; Zsanett Csoma; Lajos Kemény; Márta Széll; Nikoletta Nagy
Journal:  Eur J Med Res       Date:  2017-06-19       Impact factor: 2.175

Review 9.  Oculocutaneous albinism.

Authors:  Karen Grønskov; Jakob Ek; Karen Brondum-Nielsen
Journal:  Orphanet J Rare Dis       Date:  2007-11-02       Impact factor: 4.123

10.  Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1).

Authors:  Vadieh Ghodsinejad Kalahroudi; Behnam Kamalidehghan; Ahoura Arasteh Kani; Omid Aryani; Mahdi Tondar; Fatemeh Ahmadipour; Lip Yong Chung; Massoud Houshmand
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.